{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:19:06Z","timestamp":1773663546407,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Foundation of Research Support in Rio de Janeiro \u2013 FAPERJ","award":["E-26\/170.922\/2004"],"award-info":[{"award-number":["E-26\/170.922\/2004"]}]},{"name":"Foundation of Research Support in Rio de Janeiro \u2013 FAPERJ","award":["E-26\/111.334\/2011"],"award-info":[{"award-number":["E-26\/111.334\/2011"]}]},{"name":"National Council for Scientific and Technological Development \u2013 CNPq","award":["476116\/2009-0"],"award-info":[{"award-number":["476116\/2009-0"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s13277-016-4850-3","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T08:06:13Z","timestamp":1454659573000},"page":"10469-10478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Roles of CDKN1A gene polymorphisms (rs1801270 and rs1059234) in the development of cervical neoplasia"],"prefix":"10.1007","volume":"37","author":[{"given":"Sandra Liliana","family":"Vargas-Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyzabeth Avvad","family":"Portari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Lima","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evandro Mendes","family":"Klumb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helo\u00edsa Carneiro","family":"da Rocha Guillobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9","family":"de Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00edntia Barros","family":"Santos-Rebou\u00e7as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio Bastos","family":"Russomano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacyara Maria Brito","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"4850_CR1","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http:\/\/globocan.iarc.fr . Accessed 05 July 2015."},{"key":"4850_CR2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342\u201350.","journal-title":"Nat Rev Cancer"},{"key":"4850_CR3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2012.03.047","volume":"126","author":"CA Freitas de","year":"2012","unstructured":"de Freitas CA, Almeida Diniz Gurgel AP, Chagas BS, Coimbra EC, do Amaral CM. Susceptibility to cervical cancer: an overview. Gynecol Oncol. 2012;126:304\u201311.","journal-title":"Gynecol Oncol"},{"key":"4850_CR4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","volume":"24","author":"N Mu\u00f1oz","year":"2006","unstructured":"Mu\u00f1oz N, Castellsaque X, de Gonzales AB, Gissmann L. HPV in the etiology of human cancer. Vaccine. 2006;24:S1\u201310.","journal-title":"Vaccine"},{"key":"4850_CR5","doi-asserted-by":"crossref","unstructured":"Weinberg RA. How cancer arises. Sci Am. 1996;62\u201370.","DOI":"10.1038\/scientificamerican0996-62"},{"key":"4850_CR6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS El-Deiry","year":"1993","unstructured":"El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817\u201325.","journal-title":"Cell"},{"key":"4850_CR7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400\u201314.","journal-title":"Nat Rev Cancer"},{"key":"4850_CR8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4161\/cl.21667","volume":"2","author":"N Coleman","year":"2012","unstructured":"Coleman N, Kissil J. Recent advances in the development of p21-activated kinase inhibitors. Cell Logist. 2012;2:132\u20135.","journal-title":"Cell Logist"},{"key":"4850_CR9","doi-asserted-by":"crossref","unstructured":"Overton W, Spencerb SL, Noderera WL, Meyer T, Wang CL. Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states. PNAS. 2014;e4386\u201393.","DOI":"10.1073\/pnas.1409797111"},{"key":"4850_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.20344\/amp.335","volume":"24","author":"H Souza","year":"2011","unstructured":"Souza H, Santos AM, Pinto D, Medeiros R. Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development? Acta Med Port. 2011;24:127\u201334.","journal-title":"Acta Med Port"},{"key":"4850_CR11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5732\/cjc.010.10587","volume":"30","author":"H Ma","year":"2011","unstructured":"Ma H, Zhou Z, Wei S, Wei Q. Association between p21 Ser31Arg polymorphism and cancer risk: a meta-analysis. Chin J Cancer. 2011;30:254\u201363.","journal-title":"Chin J Cancer"},{"key":"4850_CR12","unstructured":"Niehs Environmental Genome Project. [Internet] University of Washington. Available from: http:\/\/egp.gs.washington.edu\/data\/cdkn1a\/ . Accessed 25 Nov 14."},{"key":"4850_CR13","first-page":"3021","volume":"9","author":"M Chedid","year":"1994","unstructured":"Chedid M, Michieli P, Lengel C, Huppi K, Givol D. A single nucleotide substitution at codon 31 (Ser\/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1\/CIP1. Oncogene. 1994;9:3021\u20134.","journal-title":"Oncogene"},{"key":"4850_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000154344","volume":"46","author":"R Birgander","year":"1996","unstructured":"Birgander R, Sjalander A, Saha N, et al. The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups. Hum Hered. 1996;46:148\u201354.","journal-title":"Hum Hered"},{"key":"4850_CR15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2005.06.007","volume":"99","author":"P Bhattacharya","year":"2005","unstructured":"Bhattacharya P, Sengupta S. Lack of evidence that proline homozygosity at cod\u00f3n 72 of p53 and rare arginine allele at cod\u00f3n 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. Gynecol Oncol. 2005;99:176\u201382.","journal-title":"Gynecol Oncol"},{"key":"4850_CR16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/abbs\/gmq069","volume":"42","author":"P Jiang","year":"2010","unstructured":"Jiang P, Liu J, Li W, Zeng X, Tang J. Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women. Acta Biochim Biophys Sin. 2010;42:671\u20136.","journal-title":"Acta Biochim Biophys Sin"},{"key":"4850_CR17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/IGC.0b013e3181a8b950","volume":"19","author":"Q Tian","year":"2009","unstructured":"Tian Q, Lu W, Chen H, Ye F, Xie X. The nonsynonymous single-nucleotide polymorphisms in codon 31 of p21 gene and the susceptibility to cervical cancer in Chinese women. Int J Gynecol Cancer. 2009;19:1011\u20134.","journal-title":"Int J Gynecol Cancer"},{"key":"4850_CR18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3727\/096504010X12671222663719","volume":"18","author":"JW Roh","year":"2010","unstructured":"Roh JW, Kim BK, Lee CH, Kim J, Chung HH, Kim JW, et al. p53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women. Oncol Res. 2010;18:453\u20139.","journal-title":"Oncol Res"},{"key":"4850_CR19","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1007\/s13277-013-0976-8","volume":"34","author":"Y Ma","year":"2013","unstructured":"Ma Y, Zhang Y, Lin L, Guo X, Wu Y, Wen W, et al. Quantitative assessment of the relationship between p21 Ser31Arg polymorphism and cervical cancer. Tumour Biol. 2013;34:3887\u201392.","journal-title":"Tumour Biol"},{"key":"4850_CR20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/1471-2407-12-589","volume":"12","author":"N Wang","year":"2012","unstructured":"Wang N, Wang S, Zhang Q, Lu Y, Wei H, Li W, et al. Association of p21 SNPs and risk of cervical cancer among Chinese women. BMC Cancer. 2012;12:589.","journal-title":"BMC Cancer"},{"key":"4850_CR21","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/carcin\/bgi105","volume":"9","author":"G Li","year":"2005","unstructured":"Li G, Liu Z, Sturgis EM, Shi Q, Chamberlain RM, Spitz MR, et al. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2005;9:1596\u2013602.","journal-title":"Carcinogenesis"},{"key":"4850_CR22","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1093\/carcin\/bgt308","volume":"34","author":"IN Carvalho","year":"2013","unstructured":"Carvalho IN, de Oliveira Reis AH, Cabello PH, Vargas FR. Polymorphisms of CDKN1A gene and risk of retinoblastoma. Carcinogenesis. 2013;34:2774\u20137.","journal-title":"Carcinogenesis"},{"key":"4850_CR23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/03014460.2012.742138","volume":"40","author":"FS Manta","year":"2013","unstructured":"Manta FS, Pereira R, Caiafa A, Silva DA, Gusm\u00e3o L, Carvalho EF. Analysis of genetic ancestry in the admixed Brazilian population from Rio de Janeiro using 46 autosomal ancestry informative indel markers. Ann Hum Biol. 2013;40:94\u20138.","journal-title":"Ann Hum Biol"},{"key":"4850_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/1354750X.2014.881419","volume":"9","author":"SL Vargas-Torres","year":"2014","unstructured":"Vargas-Torres SL, Portari EA, Klumb EM, Guillobel HC, de Camargo MJ, Russomano FB, et al. Association of CDKN2A polymorphisms with the severity of cervical neoplasia in a Brazilian population. Biomarkers. 2014;9:121\u20137.","journal-title":"Biomarkers"},{"key":"4850_CR25","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/0961203310372952","volume":"19","author":"EM Klumb","year":"2010","unstructured":"Klumb EM, Pinto AC, Jesus GR, Araujo Jr M, Jascone L, Gayer CR, et al. Are women with lupus at higher risk of HPV infection? Lupus. 2010;19:1485\u201391.","journal-title":"Lupus"},{"key":"4850_CR26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0923-1811(00)00096-7","volume":"24","author":"R Konishi","year":"2000","unstructured":"Konishi R, Sakatani S, Kimihiro K, Suzuki K. Polymorphisms of p21 cyclin-dependent kinase inhibitor and malignant skin tumors. J Dermatol Sci. 2000;24:177\u201383.","journal-title":"J Dermatol Sci"},{"key":"4850_CR27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1157\/13078029","volume":"19","author":"R Iniesta","year":"2005","unstructured":"Iniesta R, Guino E, Moreno V. An\u00e1lisis estad\u00edstico de polimorfismos gen\u00e9ticos en estudios epidemiol\u00f3gicos. Gac Sanit. 2005;19:333\u201341.","journal-title":"Gac Sanit"},{"key":"4850_CR28","doi-asserted-by":"crossref","unstructured":"Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats your web tool for SNP analysis. [Internet] Bioinformatics. 2006;22:1928\u20139. Available from: http:\/\/bioinfo.iconcologia.net\/snpstats\/start.htm . Accessed 10 Aug 15.","DOI":"10.1093\/bioinformatics\/btl268"},{"key":"4850_CR29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/1354750X.2014.962614","volume":"19","author":"SL Vargas-Torres","year":"2014","unstructured":"Vargas-Torres SL, Portari EA, Klumb EM, Guillobel HC, Camargo MJ, Russomano FB, et al. Effects of MDM2 promoter polymorphisms on the development of cervical neoplasia in a Southeastern Brazilian population. Biomarkers. 2014;19:637\u201345.","journal-title":"Biomarkers"},{"key":"4850_CR30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/PGP.0b013e31826f5cf6","volume":"32","author":"E Portari","year":"2013","unstructured":"Portari E, Russomano FB, De Camargo MJ, Gayer CR, Guillobel HC, Santos-Rebou\u00e7as CB, et al. Immunohistochemical expression of cyclin D1, p16Ink4a, p21WAF1, and Ki-67 correlates with the severity of cervical neoplasia. Int J Gynecol Pathol. 2013;32:501\u20138.","journal-title":"Int J Gynecol Pathol"},{"key":"4850_CR31","first-page":"167","volume":"150","author":"J Lukas","year":"1997","unstructured":"Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen WH, et al. WAF1\/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am J Pathol. 1997;150:167\u201375.","journal-title":"Am J Pathol"},{"key":"4850_CR32","first-page":"261","volume":"4","author":"Y Sun","year":"1995","unstructured":"Sun Y, Hildesheim A, Li H, Li Y, Chen JY, Cheng YJ, et al. No point mutation but a codon 31ser>arg polymorphism of the WAF-1\/CIP-1\/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiol Biomarkers Prev. 1995;4:261\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4850_CR33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0169-5002(03)00081-3","volume":"40","author":"L Su","year":"2003","unstructured":"Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W, et al. p53 (codon 72) and p21 (codon 31) polymorphisms alter in vivo mRNA expression of p21. Lung Cancer. 2003;40:259\u201366.","journal-title":"Lung Cancer"},{"key":"4850_CR34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-0714.2007.00604.x","volume":"37","author":"CC Gomes","year":"2008","unstructured":"Gomes CC, Drummond SN, Guimar\u00e3es AL, Andrade CI, Mesquita RA, Gomez RS. p21\/ WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med. 2008;37:151\u20136.","journal-title":"J Oral Pathol Med"},{"key":"4850_CR35","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1590\/S1516-31802009000500008","volume":"127","author":"MD Valentin","year":"2009","unstructured":"Valentin MD, Canalle R, Queiroz Rde P, Tone LG. Frequency of polymorphisms and protein expression of cyclin-dependent kinase inhibitor 1A (CDKN1A) in central nervous system tumors. Sao Paulo Med J. 2009;127:288\u201394.","journal-title":"Sao Paulo Med J"},{"key":"4850_CR36","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/modpathol.2010.85","volume":"23","author":"EY Chen","year":"2010","unstructured":"Chen EY, Tran A, Raho CJ, Birch CM, Crum CP, Hirsch MS. Histological \u2018progression\u2019 from low (LSIL) to high (HSIL) squamous intraepithelial lesion is an uncommon event and an indication for quality assurance review. Mod Pathol. 2010;23:1045\u201351.","journal-title":"Mod Pathol"},{"key":"4850_CR37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0304-3835(01)00401-3","volume":"165","author":"JW Roh","year":"2001","unstructured":"Roh JW, Kim MH, Kim JW, Park N, Song Y, Kang S, et al. Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women. Cancer Lett. 2001;165:59\u201362.","journal-title":"Cancer Lett"},{"key":"4850_CR38","first-page":"261","volume":"7","author":"Y Harima","year":"2001","unstructured":"Harima Y, Sawada S, Nagata K, Sougawa M, Ostapenko V, Ohnishi T. Polymorphism of the WAF1 gene is related to susceptibility to cervical cancer in Japanese women. Int J Mol Med. 2001;7:261\u20134.","journal-title":"Int J Mol Med"},{"key":"4850_CR39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/mutage\/ger010","volume":"26","author":"F Liu","year":"2011","unstructured":"Liu F, Li B, Wei Y, Chen X, Ma Y, Yan L, et al. p21 codon 31 polymorphism associated with cancer among white people: evidence from a meta-analysis involving 78074 subjects. Mutagenesis. 2011;26:513\u201321.","journal-title":"Mutagenesis"},{"key":"4850_CR40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.cdd.4401546","volume":"12","author":"B Tanno","year":"2005","unstructured":"Tanno B, Cesi V, Vitali R, Sesti F, Giuffrida ML, Mancini C, et al. Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblas- toma cells. Cell Death Differ. 2005;12:213\u201323.","journal-title":"Cell Death Differ"},{"key":"4850_CR41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc2867","volume":"10","author":"BM Ryan","year":"2010","unstructured":"Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10:389\u2013402.","journal-title":"Nat Rev Cancer"},{"key":"4850_CR42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","volume":"6","author":"MD Jansson","year":"2012","unstructured":"Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6:590\u2013610.","journal-title":"Mol Oncol"},{"key":"4850_CR43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20:460\u20139.","journal-title":"Trends Mol Med"},{"key":"4850_CR44","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1038\/onc.2010.34","volume":"29","author":"S Wu","year":"2010","unstructured":"Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, et al. Multiple microRNAs modulate p21Cip1\/Waf1 expression by directly targeting its 3\u2032 untranslated region. Oncogene. 2010;29:2302\u20138.","journal-title":"Oncogene"},{"key":"4850_CR45","unstructured":"National Center for Biotechnology Information, U.S. National Library of Medicine. Available from: http:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=1059234 . Accessed 08 Sept 2015"},{"key":"4850_CR46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12013-014-0180-5","volume":"71","author":"D Yin","year":"2015","unstructured":"Yin D, Jiang Y, Zhang S, Wang N, Lu Y, Wei H, et al. No association between p21 gene rs1059234 polymorphisms and risk of endometrial cancer among Han women in Northeast China. Cell Biochem Biophys. 2015;71:167\u201371.","journal-title":"Cell Biochem Biophys"},{"key":"4850_CR47","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1158\/0008-5472.CAN-09-0627","volume":"69","author":"GG Johnson","year":"2009","unstructured":"Johnson GG, Sherrington PD, Carter A, Lin K, Liloglou T, Field JK, et al. A novel type of p53 pathway dysfunction in chronic lymphocytic leukemia resulting from two interacting single nucleotide polymorphisms within the p21 gene. Cancer Res. 2009;69:5210\u20137.","journal-title":"Cancer Res"},{"key":"4850_CR48","first-page":"235","volume":"13","author":"N Taghavi","year":"2010","unstructured":"Taghavi N, Biramijamal F, Abbaszadegan MR, Khademi H, Sotoudeh M, Khoshbakht S. P21 (Waf1\/Cip1) gene polymorphisms and possible interaction with cigarette smoking in esophageal squamous cell carcinoma in northeastern Iran: a preliminary study. Arch Iran Med. 2010;13:235\u201342.","journal-title":"Arch Iran Med"},{"key":"4850_CR49","unstructured":"Solovyev V, Sagitov V. Softberry, Inc., 2015. Available from: http:\/\/www.softberry.com . Accessed on 08 Sept 2015."},{"key":"4850_CR50","doi-asserted-by":"crossref","unstructured":"Chang TH, Huang HY, Hsu JB, Weng SL, Horng JT, Huang HD. An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs. BMC Bioinf. 2013;14 Suppl2:S4. Available from: http:\/\/regrna2.mbc.nctu.edu.tw\/ . Accessed 08 Sept 2015.","DOI":"10.1186\/1471-2105-14-S2-S4"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-4850-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-016-4850-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-4850-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-4850-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T19:25:03Z","timestamp":1692213903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-016-4850-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["4850"],"URL":"https:\/\/doi.org\/10.1007\/s13277-016-4850-3","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]}}}